Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Raised by Morris Financial Concepts Inc.

Morris Financial Concepts Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 465 shares of the medical equipment provider’s stock after acquiring an additional 50 shares during the quarter. Morris Financial Concepts Inc.’s holdings in Intuitive Surgical were worth $243,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in the company. Bennett Selby Investments LP increased its position in Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the last quarter. LVW Advisors LLC increased its position in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. boosted its stake in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Journey Strategic Wealth LLC boosted its stake in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after acquiring an additional 19 shares in the last quarter. Finally, FSM Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $275,000 after acquiring an additional 19 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

ISRG opened at $589.61 on Thursday. The firm has a 50 day simple moving average of $556.91 and a 200 day simple moving average of $516.98. The company has a market cap of $210.01 billion, a price-to-earnings ratio of 91.98, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 6,348 shares of company stock valued at $3,587,582 over the last three months. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on ISRG shares. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Royal Bank of Canada upped their price target on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Piper Sandler reiterated an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Finally, Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.